[Federal Register Volume 65, Number 117 (Friday, June 16, 2000)]
[Notices]
[Pages 37790-37791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-15253]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-00-40]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Seleda Perryman, CDC-
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

Proposed Project

    Exposure to Aerosolized Brevetoxins During Red Tide Events--New--
National Center for Environmental Health (NCEH). Gymnodinium breve is 
the marine dinoflagellate responsible for extensive blooms (called red 
tides) that form in the gulf of Mexico. G. breve produces potent 
toxins, called brevetoxins, that have been responsible for killing 
millions of fish and other marine organisms. The biochemical activity 
of brevetoxins is not completely understood and there is very little 
information regarding human health effects from environmental 
exposures, such as inhaling brevetoxin that has been aerosolized and 
swept onto the coast by offshore winds. The National Center for 
Environmental Health (NCEH), Centers for Disease Control and Prevention 
(CDC) is planning to recruit 100 people who work along the coast of 
Florida and who potentially will be occupationally exposed to 
aerosolized red tide toxins some time during the year following 
recruitment.
    NCEH plans on administering a base-line respiratory health 
questionnaire and conducting pre- and post-shift pulmonary function 
tests during a time when there is no red tide reported near the area. 
When a red tide develops, we plan to administer a symptom survey and 
conduct pulmonary function testing (PFT) on a group of study 
participants who are working in the area where the red tide is near 
shore, and on a control group of study participants who are not working 
in an area where the red tide is near shore (i.e., are not exposed to 
the red tide). We will then compare (1) symptom reports before and 
during the red tide and (2) the changes in baseline PFT values during 
the work shift (differences between pre- and post-shift PFT results 
without exposure to red tide) with the changes in PFT values during the 
work shift when individuals are exposed to red tide. In addition, we 
plan to assist in collecting biological specimens (inflammatory cells 
from nose and throat swabs) to assess whether they can be used to 
verify exposure and to demonstrate a biological effect (i.e., 
inflammatory response) from exposure to red tide. There are no costs to 
respondents.

----------------------------------------------------------------------------------------------------------------
                                                                      No. of      Average burden
                   Respondents                        No. of       responses per   per response    Total burden
                                                    respondents     respondent       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Pulmonary History Questionnaire.................             100               1           20/60              33
Symptom Questionnaire...........................             100              20            5/60             167
Nasal and throat swabs..........................             100              20            5/60             167
Pulmonary Function Tests........................             100              20           20/60             667
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............            1034
----------------------------------------------------------------------------------------------------------------



[[Page 37791]]

    Dated: June 12, 2000.
Kathy Cahill,
Associate Director for Policy, Planning, and Evaluation, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 00-15253 Filed 6-15-00; 8:45 am]
BILLING CODE 4163-18-P